Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo
Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Data for children aged 2 months to <18 years recrui...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2020-03-01
|
| Series: | International Journal of Women's Dermatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647519301169 |